Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biology of Blood and Marrow Transplantation - Volume 22, Issue 2, February 2016, Pages 307-315

Sonata Jodele, Tsuyoshi Fukuda, Kana Mizuno, Alexander A. Vinks, Benjamin L. Laskin, Jens Goebel, Bradley P. Dixon, Ranjit S. Chima, Russel Hirsch, Ashley Teusink, Danielle Lazear, Adam Lane, Kasiani C. Myers, Christopher E. Dandoy, Stella M. Davies,